IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,473,211 | +164.3% | 1,028,216 | +30.6% | 0.01% | +180.0% |
Q2 2023 | $14,934,152 | +184226.7% | 787,251 | +50.7% | 0.01% | +66.7% |
Q1 2023 | $8,102 | +40.9% | 522,396 | +61.3% | 0.00% | +50.0% |
Q4 2022 | $5,750 | -99.4% | 323,918 | +81.5% | 0.00% | – |
Q3 2022 | $995,000 | +40.5% | 178,428 | -1.7% | 0.00% | – |
Q2 2022 | $708,000 | -46.5% | 181,517 | -18.6% | 0.00% | – |
Q1 2022 | $1,323,000 | -58.3% | 223,085 | -40.0% | 0.00% | -100.0% |
Q4 2021 | $3,169,000 | +1.5% | 371,950 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $3,123,000 | -25.7% | 359,307 | -9.6% | 0.00% | 0.0% |
Q2 2021 | $4,201,000 | -28.5% | 397,382 | +8.5% | 0.00% | -50.0% |
Q1 2021 | $5,874,000 | -70.1% | 366,183 | -14.0% | 0.00% | -71.4% |
Q4 2020 | $19,661,000 | +56.5% | 425,666 | +19.2% | 0.01% | +40.0% |
Q3 2020 | $12,562,000 | +172.7% | 356,980 | +88.7% | 0.01% | +150.0% |
Q2 2020 | $4,606,000 | – | 189,151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |